Home  |  About  |  Product Development  |  Contact Us
Aesthetic and Medical Botox
 
Global 2018 Botulinum Toxin Market: $4.8 billion, CAGR 12+%
Global Industry Analysts Inc 2012

“The pain felt during botulinum toxin type-A injections and the troubled and distressed treatment it induces is common and well known for the patient and the doctor applying the treatment.”
Nedim Sarifakioglu MD, Annuals of Plastic Surgery December 2004

Global 2016 Lip Filler Market: $2.4 billion, CAGR 9.5%
Millennium Research Group 2013

"Performing lip augmentation using fillers is a very common procedure. Yes, it can be painful. I would say 10% don't take any anesthetic. 80% need a topical anesthetic only and about 10% need a nerve block injection." —Wallach MD

Combined aesthetics markets total $US 7+ billion with 9+ million procedures with each procedure involving 3-4 and potentially up to 15 needle sticks. Patients need to repeat procedures every 3-6 months to achieved and maintain best results.

Aesthetic Market & Innova Product Platform

Innova’s needle pain relief technology advantages:

  • Immediate pain relief, no wait time for onset
  • No additional drugs, messy creams or ice packs
  • Individually adjusted to each patient’s needs
  • No extra prep or wait time for clinic or patient
  • Faster patient throughput, improved efficiency
  • Reduced needle pain/fear enlarges market
  • Facilitates repeat procedures and compliance
  • Differentiates physician/clinic service
  • Product development work for aesthetic procedures is confidential.

Product system underdevelopment, not yet commercially available.

 

Curious about how our technology actually works? Visit our Core Technology page:
Core Technology

 

Disclaimer: Product descriptions provided on this site are for informational purposes only. No products are offered for sale or are commercially available at this time.

 
Innova Innova Innova